D
Forte Biosciences, Inc. FBRX
$17.00 $1.338.49% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2026 12/31/2025 09/30/2025 06/30/2025 03/31/2025
Total Cash And Short-Term Investments 26.97% 31.85% 470.89% 333.28% 50.62%
Total Receivables -- 538.28% -- -- --
Inventory -- -- -- -- --
Prepaid Expenses 602.23% -9.53% -3.01% -1.78% 3.39%
Finance Division Loans and Leases Current -- -- -- -- --
Total Finance Division Other Current Assets -- -- -- -- --
Other Current Assets -46.10% 102.88% 71.90% 87.86% 92.70%
Total Current Assets 38.07% 31.37% 440.03% 318.56% 49.70%

Total Current Assets 38.07% 31.37% 440.03% 318.56% 49.70%
Net Property, Plant & Equipment -12.00% 67.53% 72.09% 14.58% 17.92%
Long-term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Total Other Intangibles -- -- -- -- --
Finance Div Loans & Leases LT -- -- -- -- --
Total Finance Div Other LT Assets -- -- -- -- --
Total Other Assets 1,038.07% 1,393.48% 696.35% -78.97% -56.97%
Total Assets 41.64% 34.47% 441.01% 313.31% 48.23%

Total Accounts Payable 160.48% 104.73% 6.44% 0.49% 198.10%
Total Accrued Expenses 140.36% 134.06% 119.26% 0.70% 143.41%
Short-term Debt -- -- -- -- --
Current Portion of Long-Term Debt/Capital Leases -- -- -- -- --
Finance Division Debt Current -- -- -- -- --
Total Finance Division Other Current Liabilities -- -- -- -- --
Total Other Current Liabilities -- -- -- -- --
Total Current Liabilities 161.81% 128.51% 51.42% 0.58% 171.07%

Total Current Liabilities 161.81% 128.51% 51.42% 0.58% 171.07%
Long-Term Debt -- -- -- -- --
Short-term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Finance Division Debt Non Current -- -- -- -- --
Total Finance Division Other Non Current Liabilities -- -- -- -- --
Total Other Liabilities -- -- -- -- --
Total Liabilities 178.16% 139.93% 51.42% 0.58% 171.07%

Common Stock & APIC 38.22% 37.73% 80.97% 79.85% 34.57%
Retained Earnings -44.71% -45.05% -35.24% -30.66% -34.71%
Treasury Stock & Other -- -72.73% -700.00% -- --
Total Common Equity 9.56% 16.22% 797.90% 481.41% 33.96%

Preferred Stock Redeemable -- -- -- -- --
Preferred Stock Non Redeemable -- -- -- -- --
Preferred Stock Convertible -- -- -- -- --
Preferred Stock, Others -- -- -- -- --
Total Preferred Equity -- -- -- -- --

Total Common Equity 9.56% 16.22% 797.90% 481.41% 33.96%
Total Preferred Equity -- -- -- -- --
Total Minority Interest -- -- -- -- --
Total Equity 9.56% 16.22% 797.90% 481.41% 33.96%